12 Einträge gefunden

1. Genomic deletion of chromosome 12p is an independent prognostic marker in prostate cancer

   1. Kluth, Martina
   2. Ahrary, Ramin
   3. Hube-Magg, Claudia
   4. Ahmed, Malik
   5. Volta, Heike
   6. Schwemin, C.
   7. Steurer, Stefan

   2015 - Forschungsinformationssystem des UKE
2. High-Level HOOK3 Expression Is an Independent Predictor of Poor Prognosis Associated with Genomic Instability in Prostate Cancer

   1. Melling, Nathaniel
   2. Harutyunyan, Levon
   3. Hube-Magg, Claudia
   4. Kluth, Martina
   5. Simon, Ronald
   6. Lebok, Patrick
   7. Minner, Sarah

   2015 - Forschungsinformationssystem des UKE - frei zugänglich
3. Overexpression of enhancer of zeste homolog 2 (EZH2) characterizes an aggressive subset of prostate cancers and predicts patient prognosis independently from pre- and postoperatively assessed clinicopathological parameters

   1. Melling, Nathaniel
   2. Thomsen, Erik
   3. Tsourlakis, Maria Christina
   4. Kluth, Martina
   5. Hube-Magg, Claudia
   6. Minner, Sarah
   7. Koop, Christina

   2015 - Forschungsinformationssystem des UKE
4. VEGFR-1 overexpression identifies a small subgroup of aggressive prostate cancers in patients treated by prostatectomy

   1. Tsourlakis, Maria Christina
   2. Khosrawi, Puya
   3. Weigand, Philipp
   4. Kluth, Martina
   5. Hube-Magg, Claudia
   6. Minner, Sarah
   7. Koop, Christina

   2015 - Forschungsinformationssystem des UKE - frei zugänglich
5. Loss of SOX9 Expression Is Associated with PSA Recurrence in ERG-Positive and PTEN Deleted Prostate Cancers

   1. Burdelski, Christoph
   2. Bujupi, Erzen
   3. Tsourlakis, Maria Christina
   4. Hube-Magg, Claudia
   5. Kluth, Martina
   6. Melling, Nathaniel
   7. Lebok, Patrick

   2015 - Forschungsinformationssystem des UKE - frei zugänglich
6. HDAC1 overexpression independently predicts biochemical recurrence and is associated with rapid tumor cell proliferation and genomic instability in prostate cancer

   1. Burdelski, Christoph
   2. Ruge, Oliver M
   3. Melling, Nathaniel
   4. Koop, Christina
   5. Simon, Ronald
   6. Steurer, Stefan
   7. Sauter, Guido

   2015 - Forschungsinformationssystem des UKE
7. Saccharomyces cerevisiae-like 1 overexpression is frequent in prostate cancer and has markedly different effects in Ets-related gene fusion-positive and fusion-negative cancers

   1. Burdelski, Christoph
   2. Barreau, Ysé
   3. Simon, Ronald
   4. Hube-Magg, Claudia
   5. Minner, Sarah
   6. Koop, Christina
   7. Graefen, Markus

   2015 - Forschungsinformationssystem des UKE
8. Cytoplasmic Accumulation of Sequestosome 1 (p62) Is a Predictor of Biochemical Recurrence, Rapid Tumor Cell Proliferation, and Genomic Instability in Prostate Cancer

   1. Burdelski, Christoph
   2. Reiswich, V.
   3. Hube-Magg, Claudia
   4. Kluth, Martina
   5. Minner, Sarah
   6. Koop, Christina
   7. Graefen, Markus

   2015 - Forschungsinformationssystem des UKE
9. Overexpression of thymidylate synthase (TYMS) is associated with aggressive tumor features and early PSA recurrence in prostate cancer

   1. Burdelski, Christoph
   2. Strauss, Christian
   3. Tsourlakis, Maria Christina
   4. Kluth, Martina
   5. Hube-Magg, Claudia
   6. Melling, Nathaniel
   7. Lebok, Patrick

   2015 - Forschungsinformationssystem des UKE
10. HOXB13 overexpression is an independent predictor of early PSA recurrence in prostate cancer treated by radical prostatectomy

    1. Zabalza, Cristina Villares
    2. Adam, Meike
    3. Burdelski, Christoph
    4. Wilczak, Waldemar
    5. Wittmer, Corinna
    6. Kraft, Stefan
    7. Krech, Till

    2015 - Forschungsinformationssystem des UKE
11. The prognostic value of SUMO1/Sentrin specific peptidase 1 (SENP1) in prostate cancer is limited to ERG-fusion positive tumors lacking PTEN deletion

    1. Burdelski, Christoph
    2. Menan, Devi
    3. Tsourlakis, Maria Christina
    4. Kluth, Martina
    5. Hube-Magg, Claudia
    6. Melling, Nathaniel
    7. Minner, Sarah

    2015 - Forschungsinformationssystem des UKE - frei zugänglich
12. Expression of DNA ligase IV is linked to poor prognosis and characterizes a subset of prostate cancers harboring TMPRSS2:ERG fusion and PTEN deletion

    1. Grupp, Katharina
    2. Roettger, Laura
    3. Kluth, Martina
    4. Hube-Magg, Claudia
    5. Simon, Ronald
    6. Lebok, Patrick
    7. Minner, Sarah

    2015 - Forschungsinformationssystem des UKE